Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001439222-21-000031)

Filing Details

Accession Number:: 0001439222-21-000031
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-16 16:14:21
Reporting Period:: 2021-03-01

Accepted Time:: 2021-03-16 16:14:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1439222	Agios Pharmaceuticals Inc.	AGIO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1840076	Darrin Miles	C/O Agios Pharmaceuticals Inc. 88 Sidney Street Cambridge MA 02139	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-03-01	2,200	$47.99	11,171	No	4	S	Direct
Common Stock	Disposition	2021-03-05	500	$48.58	10,671	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Includes 314 shares purchased through the Company's employee stock purchase plan.